Clinical Trials Logo

Filter by:
NCT ID: NCT04382508 Enrolling by invitation - Infection Clinical Trials

Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.

ImmunoCOVID
Start date: March 22, 2020
Phase:
Study type: Observational

A weekly questionnaire is sent to patients and parents of patients who are vulnerable for infections. Possible symptoms of COVID19 are asked for and use of healthcare services and testing for COVID19. Weekly reports are being send to the national institutions to update advice given to this group.

NCT ID: NCT04365114 Enrolling by invitation - Breast Cancer Clinical Trials

Patient Outcomes From Second Film-readers and Test Threshold Relaxation in Breast Screening

POSTBOx
Start date: October 1, 2018
Phase:
Study type: Observational

Analysis of women's medical records to understand the impact of previous changes to breast cancer screening (increase from one to two clinicians examining each woman's mammograms, and what proportion of women they recall for further tests)

NCT ID: NCT04363047 Enrolling by invitation - SARS Virus Clinical Trials

Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19

Start date: October 1, 2020
Phase:
Study type: Observational

A team at the University of Manchester are developing a test that tcould be helpful in detecting immunity to the Coronavirus (which causes the COVID-19 disease) in participants with inflammatory arthritis. It is based on a flu assay has already developed; the team will replace the flu antigen with a Coronavirus antigen to see if it is effective. This project aims to develop a test to see if people who have had the virus have developed immunity to it. This could help to predict who might or might not get the disease a second time, who should stay at home to be protected from potential infection or who will not develop any symptoms, even if exposed to the virus. When vaccination trials against the Coronavirus will be launched, this test could also help to see if the vaccine is effective.

NCT ID: NCT04322071 Enrolling by invitation - Type 1 Diabetes Clinical Trials

Family Factors in Young People With Diabetes: a Qualitative Study

Start date: February 26, 2020
Phase:
Study type: Observational

8 young people (aged 12-15yrs) with type 1 diabetes will be interviewed along with their families during this qualitative study. The interviews will explore factors identified by the young people and their families as important in diabetes management. Comparison of these factors will then be made between the young people with higher and lower HbA1c levels.

NCT ID: NCT04318106 Enrolling by invitation - Visual Stress Clinical Trials

Reading; Through the Eyes of a University Student

Start date: January 27, 2020
Phase: N/A
Study type: Interventional

This is a double-masked randomized controlled trial which aims to assess the effects of precision tinted spectacle lenses on visual stress symptoms within an undergraduate University student population.

NCT ID: NCT04312802 Enrolling by invitation - Clinical trials for Diabetes Mellitus, Type 1

Cardiopulmonary Testing for Potential Pancreas Transplant Candidates

Start date: March 1, 2018
Phase:
Study type: Observational

Patients being assessed for Kidney Pancreas transplantation often have pre-existing co-morbid disease that contributes to structural cardiac and vascular disease. There is no consensus on optimal pre-listing cardiac assessment to reliably minimize risk of peri-operative cardiac events. Functional status using the cardio-pulmonary exercise test (CPET) has been used in cardiac and abdominal surgery, including abdominal aortic aneurysm (AAA) repair and kidney transplantation, but high risk patients with diabetes are often lacking from these studies. This study will investigate the correlation between function, measures using CPET and standard cardiac assessment, and determine the variation in usual measures of anaerobic threshold and VO2 max in this population.

NCT ID: NCT04290416 Enrolling by invitation - Epilepsy Clinical Trials

Human Single Neuron Recordings in Epilepsy Patients

Start date: February 4, 2016
Phase: N/A
Study type: Interventional

This study uses single neuron recordings in pre-surgical epilepsy patients to uncover the neural mechanisms underlying memory formation and retrieval. A secondary aim is to improve diagnostic tools to identify epileptogenic tissue.

NCT ID: NCT04261114 Enrolling by invitation - Chronic Pain Clinical Trials

Exploring the Link Between Pain and Distress in Adolescent Patients With Chronic Pain

Start date: June 13, 2022
Phase:
Study type: Observational

The primary aim is to explore what it is about the experience of chronic pain that may cause emotional distress in some young people but not in others, and how particular individual characteristics, as well as family factors may contribute to young persons' pain experiences and their emotional responses to pain.

NCT ID: NCT04208529 Enrolling by invitation - Sickle Cell Disease Clinical Trials

A Long-term Follow-up Study in Participants Who Received CTX001

Start date: January 20, 2021
Phase: Phase 3
Study type: Interventional

This is a multi-site, open- label rollover study to evaluate the long-term safety and efficacy of CTX001 in pediatric and adult participants who received CTX001 in parent studies 111 (NCT03655678) 141 (NCT05356195) or 161 (NCT05477563) (transfusion-dependent β-thalassemia [TDT] studies) or Study 121 (NCT03745287) or 151 (NCT05329649), 161(NCT05477563),171 (NCT05951205) (severe sickle cell disease [SCD] studies).

NCT ID: NCT04185636 Enrolling by invitation - Clinical trials for Skin Graft (Allograft)(Autograft) Failure

Presence of Fluorescence Signature to Predict Graft Failure Using MolecuLight i:X

Start date: January 15, 2021
Phase:
Study type: Observational

This study will investigate whether the presence of a bacterial fluorescent signature captured by the MolecuLight i:X can predict a skin graft failure. The MolecuLight i:X is a handheld medical device which enables real-time standard digital imaging and fluorescence imaging of wounds and surrounding healthy skin of patients. When wounds are illuminated in fluorescence mode, collagen and other related proteins in the connective tissue matrix may emit a characteristic green fluorescent signal, while some bacteria may emit a unique red fluorescence signal due to endogenous porphyrin production and others may emit a unique cyan fluorescence signal due to the production of pyoverdine. This is a non-randomized evaluation for which 20 adult patients will be imaged at University Hospitals Birmingham who present with a wound which has been previously infected and which requires a skin graft. The i:X will be used to take standard and fluorescent (FL) images of each graft site by the study team. The wound will be measured using the measurement application of the i:X, using WoundStickers. The clinician will be blinded to the results of these FL images until the end of the study. In this trial, the device is not intended to guide treatment. The images will be used after a 1-month patient follow up to correlate presence of bacterial fluorescence signature to graft failure. The hypothesis is that the presence of a bacterial fluorescence signature increases the likelihood of graft failure. The ability to predict graft failure would provide clinicians with more information on which to base a patient's suitability for a graft (e.g. determining if there is a heavy bacterial load present). This may lead to selection of appropriate therapies before a graft is applied.